APA (7th ed.) Citation

Papadopoulos, K. P., & Nagorsen, D. (2017). First-in-human study of AMG 820, a monoclonal anti-colony-stimulating factor 1 receptor antibody, in patients with advanced solid tumors. Clinical cancer research, 23(19), . https://doi.org/10.1158/1078-0432.CCR-16-3261

Chicago Style (17th ed.) Citation

Papadopoulos, Kyriakos P., and Dirk Nagorsen. "First-in-human Study of AMG 820, a Monoclonal Anti-colony-stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors." Clinical Cancer Research 23, no. 19 (2017). https://doi.org/10.1158/1078-0432.CCR-16-3261.

MLA (9th ed.) Citation

Papadopoulos, Kyriakos P., and Dirk Nagorsen. "First-in-human Study of AMG 820, a Monoclonal Anti-colony-stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors." Clinical Cancer Research, vol. 23, no. 19, 2017, https://doi.org/10.1158/1078-0432.CCR-16-3261.